Assessment of etiology and pharmacotherapy of patients with anemia in chronic myeloid leukemia: Challenges and opportunities in a tertiary care government hospital

Background: Chronic Myeloid Leukaemia (CML) is the most prevalent blood malignancy in India. Anemia, splenomegaly, weight loss, fatigue are the most common symptoms and Imatinib, a first generation Tyrosine kinase inhibitor (TKI) is the choice of treatment. Aim: The objective of the study was to...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ritadeepa Jana, Shuvra Neel Baul, Sandeep Saha, Suman Chattopadhyay, Ananya Mandal, Arijit Ghosh
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Eldaghayes Publisher 2024-12-01
Цуврал:	National Journal of Physiology, Pharmacy and Pharmacology
Нөхцлүүд:	chronic myeloid leukemia imatinib mesylate adverse drug reaction
Онлайн хандалт:	http://www.ejmanager.com/fulltextpdf.php?mno=227780
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!